Clinical Trial

To Evaluate the Safety and Pharmacokinetic Characteristics of AJU-C716 and C716R in Healthy Adults

Completed Phase 1
View on ClinicalTrials.gov →
Summary
To Evaluate the Safety and Pharmacokinetic Characteristics of AJU-C716 and C716R in Healthy Adults
Protocol Amendment History 1 change
critical Trial completed 2026-07-11
Trial Details
NCT Number NCT07655960
Lead Sponsor AJU Pharm Co., Ltd.
Conditions Hypercholesterolemia, Dyslipidemia
Enrollment 41 participants
Start Date 2026-06-11
Primary Completion 2026-06-19 (estimated)
Study Completion 2026-07-03 (estimated)
Updated on ClinicalTrials.gov 2026-07-10